Hastie Claire, Saxton Malcolm, Akpan Akunna, Cramer Rainer, Masters John R, Naaby-Hansen Soren
Prostate Cancer Research Centre, Royal Free and University College London Medical School, UK.
Oncogene. 2005 Sep 1;24(38):5905-13. doi: 10.1038/sj.onc.1208747.
Differences in the expression of cell surface proteins between a normal prostate epithelial (1542-NP2TX) and a prostate cancer cell line (1542-CP3TX) derived from the same patient were investigated. A combination of affinity chromatographic purification of biotin-tagged surface proteins with mass spectrometry analysis identified 26 integral membrane proteins and 14 peripheral surface proteins. The findings confirm earlier reports of altered expression in prostate cancer for several cell surface proteins, including ALCAM/CD166, the Ephrin type A receptor, EGFR and the prostaglandin F2 receptor regulatory protein. In addition, several novel findings of differential expression were made, including the voltage-dependent anion selective channel proteins Porin 1 and 2, ecto-5'-nucleotidase (CD73) and Scavenger receptor B1. Cell surface protein expression changed both qualitatively and quantitatively when the cells were grown in the presence of either or both interferon INFalpha and INFgamma. Costimulation with type I and II interferons had additive or synergistic effects on the membrane density of several, mainly peripherally attached surface proteins. Concerted upregulation of surface exposed antigens may be of benefit in immuno-adjuvant-based treatment of interferon-responsive prostate cancer. In conclusion, this study demonstrates that differences in the expression of membrane proteins between normal and prostate cancer cells are reproducibly detectable following vectorial labelling with biotin, and that detailed analysis of extracellular-induced surface changes can be achieved by combining surface-specific labelling with high-resolution two-dimensional gel electrophoresis and mass spectrometry.
研究了源自同一患者的正常前列腺上皮细胞系(1542-NP2TX)和前列腺癌细胞系(1542-CP3TX)之间细胞表面蛋白表达的差异。通过亲和色谱法纯化生物素标记的表面蛋白并结合质谱分析,鉴定出26种整合膜蛋白和14种外周表面蛋白。这些发现证实了早期关于几种细胞表面蛋白在前列腺癌中表达改变的报道,包括活化白细胞黏附分子/CD166、Ephrin A型受体、表皮生长因子受体和前列腺素F2受体调节蛋白。此外,还发现了一些新的差异表达结果,包括电压依赖性阴离子选择性通道蛋白孔蛋白1和2、胞外5'-核苷酸酶(CD73)和清道夫受体B1。当细胞在干扰素INFα和/或INFγ存在下生长时,细胞表面蛋白表达在质量和数量上均发生变化。I型和II型干扰素的共刺激对几种主要是外周附着的表面蛋白的膜密度具有累加或协同作用。表面暴露抗原的协同上调可能有利于基于免疫佐剂的干扰素反应性前列腺癌治疗。总之,本研究表明,用生物素进行定向标记后,可重复检测到正常细胞与前列腺癌细胞之间膜蛋白表达的差异,并且通过将表面特异性标记与高分辨率二维凝胶电泳和质谱分析相结合,可实现对细胞外诱导的表面变化的详细分析。